103 results
424B5
ys5318wa5 wyfdxv
2 Nov 23
Prospectus supplement for primary offering
4:59pm
8-K/A
EX-99.3
sd0bume9sij3 fkw
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K/A
EX-99.4
oewlqon9
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
EX-99.1
8l90nr2j1svn jg85
13 Oct 23
Other Events
4:16pm
8-K
EX-99.1
vap cvb3f
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
EX-10.1
ek4aytr67b7j7kkl
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-2.1
jki2jj39g9rzukl4o1
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
4e9degfrrgl wanriu
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am